Redpoint Investment Management Pty LTD Biogen Inc. Transaction History

Redpoint Investment Management Pty LTD

$684 Million
Q3 2022

A detailed history of Redpoint Investment Management Pty LTD transactions in Biogen Inc. stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 4,187 shares of BIIB stock, worth $588,859. This represents 0.16% of its overall portfolio holdings.

Number of Shares

4,187

Previous 4,234 1.11%

Holding current value

$588,859

Previous $863,000 29.55%

% of portfolio

0.16%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$194.69 - $268.46 $9,150 - $12,617	-47 Reduced 1.11%	4,187 $1.12 Million
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $15,002 - $19,280	-67 Reduced 1.56%	4,234 $1.02 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $29,147 - $38,012	-103 Reduced 2.34%	4,301 $1.22 Million
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $22,015 - $35,250	-85 Reduced 1.89%	4,404 $1.53 Million
Q4 2020 Jan 13, 2021	SELL	$236.26 - $355.63 $89,070 - $134,072	-377 Reduced 7.75%	4,489 $1.1 Million
Q3 2020 Oct 09, 2020	SELL	$264.77 - $305.71 $2.51 Million - $2.9 Million	-9,475 Reduced 66.07%	4,866 $1.38 Million
Q2 2020 Jul 17, 2020	SELL	$258.66 - $342.55 $483,694 - $640,568	-1,870 Reduced 11.54%	14,341 $3.84 Million
Q1 2020 Apr 22, 2020	SELL	$268.85 - $341.04 $2.06 Million - $2.62 Million	-7,679 Reduced 32.14%	16,211 $5.13 Million
Q4 2019 Feb 25, 2020	SELL	$220.06 - $304.07 $225,781 - $311,975	-1,026 Reduced 4.12%	23,890 $7.09 Million
Q3 2019 Nov 26, 2019	BUY	$217.44 - $243.88 $670,367 - $751,882	3,083 Added 14.12%	24,916 $5.8 Million
Q2 2019 Aug 07, 2019	BUY	$219.29 - $241.72 $666,860 - $735,070	3,041 Added 16.18%	21,833 $5.11 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $470,043 - $735,204	2,169 Added 13.05%	18,792 $4.44 Million
Q4 2018 Feb 05, 2019	SELL	$278.5 - $352.75 $970,851 - $1.23 Million	-3,486 Reduced 17.34%	16,623 $5 Million
Q3 2018 Nov 08, 2018	SELL	$293.51 - $383.83 $155,560 - $203,429	-530 Reduced 2.57%	20,109 $7.11 Million
Q2 2018 Aug 09, 2018	SELL	$257.52 - $306.91 $42,490 - $50,640	-165 Reduced 0.79%	20,639 $5.99 Million
Q1 2018 Aug 09, 2018	BUY	$260.13 - $367.91 $71,015 - $100,439	273 Added 1.33%	20,804 $5.7 Million
Q4 2017 Aug 09, 2018	BUY	$307.64 - $344.58 $6.32 Million - $7.07 Million	20,531	20,531 $6.54 Million

Others Institutions Holding BIIB

# of Institutions

997

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.

Account

Redpoint Investment Management Pty LTD Biogen Inc. Transaction History